In a significant scientific breakthrough, researchers at the Water Research Center have successfully demonstrated that an advanced electrochemical oxidation system can eliminate up to 99 percent of pharmaceutical contaminants from wastewater under controlled laboratory conditions. The technology, developed over three years of intensive bench-scale experimentation, applies a combination of electro-Fenton oxidation and high-performance boron-doped diamond anodes to rapidly break down a broad spectrum of pharmaceutical micropollutants — including antibiotics, synthetic hormones, anti-inflammatory drugs, and psychiatric medications — that routinely pass through conventional wastewater treatment processes unaltered. The findings, published this week in the peer-reviewed Journal of Hazardous Materials, have been hailed as a major step forward in the global effort to eliminate pharmaceutical pollution from water systems.

“Pharmaceutical contamination is one of the silent crises of modern water management,” said Dr. Ingrid Santos, director of the WRC’s Advanced Treatment Technologies Laboratory. “These compounds disrupt aquatic endocrine systems, contribute to the proliferation of antimicrobial-resistant organisms, and ultimately find their way back into the water we drink. Our system offers, for the first time, a practical and scalable solution to this problem.” The research demonstrated that the electrochemical process not only degrades parent pharmaceutical compounds but also mineralizes the majority of potentially toxic transformation by-products, a critical advantage over competing treatment approaches that often generate harmful intermediate chemicals.

The WRC is now transitioning the technology from the laboratory to a pilot-scale demonstration facility to be constructed at a partner municipal wastewater treatment plant. The pilot program, expected to become operational by early 2027, will assess real-world performance across varying influent compositions, seasonal fluctuations, and continuous operational loads. Energy efficiency remains a key focus of the scale-up phase, with the engineering team working to reduce power consumption per cubic meter of treated water by optimizing electrode configurations and reactor hydraulics.

Industry and government stakeholders have expressed strong interest in the technology’s commercial potential. The WRC has entered into a preliminary memorandum of understanding with two environmental engineering firms to explore licensing arrangements and joint development of a modular treatment unit suitable for deployment in hospitals, pharmaceutical manufacturing facilities, and small-scale municipal systems. Regulatory authorities have been engaged early in the process to streamline the technology’s pathway to certification and market adoption. If the pilot phase delivers results consistent with laboratory findings, the WRC estimates that the system could be ready for full-scale commercial deployment within four to five years.